Latest Period
n/a
Security Snapshot
CHINA PHARMA HLDGS INC - COM (CPHI) Institutional Ownership
CUSIP: 16941T104
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- Symbol
- CPHI on NYSE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- CPHI - CHINA PHARMA HLDGS INC - COM is tracked under CUSIP 16941T104.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 7 to 0 between Q4 2022 and Q1 2023.
- Reported value moved from $87,326 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
16941T104
Latest holder period
n/a
13F holders
13D/G owners
0
CIK / CUSIP context first
CPHI full holder history
CHINA PHARMA HOLDINGS, INC. SEC filings
CHINA PHARMA HOLDINGS, INC. company facts
CHINA PHARMA HOLDINGS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 16941T104:
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
37
Latest
n/a
Rows shown
1-25 of 37
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$87,326 | 0 | |
| 2022 Q4 | 898,253 | $87,326 | +$30,045 | $0.10 | 7 |
| 2022 Q3 | 584,826 | $77,000 | -$31,051 | $0.13 | 6 |
| 2022 Q2 | 744,386 | $159,000 | +$7,609 | $0.21 | 7 |
| 2022 Q1 | 673,176 | $262,000 | -$79,909 | $0.39 | 10 |
| 2021 Q4 | 879,474 | $423,724 | -$177,689 | $0.48 | 7 |
| 2021 Q3 | 1,245,429 | $695,000 | +$73,670 | $0.56 | 6 |
| 2021 Q2 | 1,092,339 | $789,000 | -$69,448 | $0.72 | 7 |
| 2021 Q1 | 1,189,019 | $998,000 | +$18,574 | $0.84 | 5 |
| 2020 Q4 | 1,199,903 | $534,000 | -$22,917 | $0.44 | 8 |
| 2020 Q3 | 1,260,483 | $460,000 | +$27,747 | $0.37 | 5 |
| 2020 Q2 | 1,164,899 | $775,000 | +$87,596 | $0.66 | 6 |
| 2020 Q1 | 1,027,686 | $518,000 | +$30,960 | $0.50 | 3 |
| 2019 Q4 | 1,008,923 | $239,000 | +$26,627 | $0.24 | 6 |
| 2019 Q3 | 898,712 | $220,000 | -$37,509 | $0.24 | 6 |
| 2019 Q2 | 998,056 | $322,000 | -$36,440 | $0.32 | 6 |
| 2019 Q1 | 1,111,131 | $368,000 | +$92,634 | $0.33 | 5 |
| 2018 Q4 | 893,866 | $231,000 | +$30,805 | $0.26 | 9 |
| 2018 Q3 | 782,675 | $159,000 | -$40,531 | $0.20 | 6 |
| 2018 Q2 | 961,691 | $210,000 | -$40,164 | $0.22 | 8 |
| 2018 Q1 | 1,141,410 | $362,000 | +$87,323 | $0.32 | 9 |
| 2017 Q4 | 2,547,950 | $443,000 | -$4,182 | $0.18 | 8 |
| 2017 Q3 | 2,558,155 | $446,000 | +$41,464 | $0.17 | 6 |
| 2017 Q2 | 2,335,902 | $537,000 | -$55,411 | $0.23 | 9 |
| 2017 Q1 | 2,577,638 | $670,000 | +$20,153 | $0.26 | 9 |